are bpc-157 and tb-500 approved by fda What to Know About Peptides the Is Considering for Use The FDA scheduled a hearing

One is what is in the injection, as some agents may work better for some patients than others

What might this mean for peptides in the U.S

Adding oral B12, sublingual B12, or additional B12 injections poses no risk

These therapeutic approaches are currently regarded as experimental and off-label, and patients should be fully informed of the limited empirical support for their efficacy and safety in these contexts

People with a known allergy to cobalamin or cobalt should avoid them, and those with Leber's hereditary optic neuropathy should not receive B12

It may be even more interesting and more effective than that of comparative standard agents (Sikiric et al., 1993